Percheron Therapeutics Ltd
ASX:PER
Intrinsic Value
The intrinsic value of one
PER
stock under the Base Case scenario is
0.002
AUD.
Compared to the current market price of 0.008 AUD,
Percheron Therapeutics Ltd
is
Overvalued by 75%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.
Let our AI break down the key assumptions behind the intrinsic value calculation for Percheron Therapeutics Ltd.
Fundamental Analysis
Revenue & Expenses Breakdown
Percheron Therapeutics Ltd
Balance Sheet Decomposition
Percheron Therapeutics Ltd
| Current Assets | 12.4m |
| Cash & Short-Term Investments | 10.2m |
| Receivables | 1.6m |
| Other Current Assets | 650.4k |
| Non-Current Assets | 35.3k |
| PP&E | 35.3k |
Free Cash Flow Analysis
Percheron Therapeutics Ltd
| AUD | |
| Free Cash Flow | AUD |
Earnings Waterfall
Percheron Therapeutics Ltd
|
Revenue
|
371.1k
AUD
|
|
Operating Expenses
|
-16.7m
AUD
|
|
Operating Income
|
-16.3m
AUD
|
|
Other Expenses
|
1.4m
AUD
|
|
Net Income
|
-14.9m
AUD
|
PER Profitability Score
Profitability Due Diligence
Percheron Therapeutics Ltd's profitability score is 46/100. The higher the profitability score, the more profitable the company is.
Score
Percheron Therapeutics Ltd's profitability score is 46/100. The higher the profitability score, the more profitable the company is.
PER Solvency Score
Solvency Due Diligence
Percheron Therapeutics Ltd's solvency score is 61/100. The higher the solvency score, the more solvent the company is.
Score
Percheron Therapeutics Ltd's solvency score is 61/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
PER Price Targets Summary
Percheron Therapeutics Ltd
Dividends
Current shareholder yield for
PER is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
PER
stock under the Base Case scenario is
0.002
AUD.
Compared to the current market price of 0.008 AUD,
Percheron Therapeutics Ltd
is
Overvalued by 75%.